Robots are learning to make human babies. Twenty have already been born.
By Elizabeth Dwoskin and Zoeann Murphy,
The Washington Post
| 10. 01. 2025
MEXICO CITY — When she walked into an IVF clinic in June, Alin Quintana knew it would be the last time she would try to conceive a child. She had prepared herself spiritually and mentally for the visit: She had traveled to a nearby state to leave prayer ribbons at a shrine dedicated to Mary Undoer of Knots, a manifestation beloved in Latin America. She had received a blessing from her priest. That morning, as Quintana and her husband wound their way for hours from the unpaved outskirts of the Mexican capital toward the swanky clinic in one of its richest neighborhoods, her mind was alert, as if she were making a recording. She was focusing on the moment, she said, to drown out the weight of painful memories — a lost pregnancy, a burst fallopian tube, emergency surgery, 96 monthly cycles of hope and crushing disappointment.
But now she was ready to be part of a generational experiment: A robot would create her baby. Chatbots have invaded our conversations and self-driving cars roam our streets, but the creation of life is a new frontier for artificial intelligence. In-vitro fertilization has produced more than 13 million babies since...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...